SoundView Advisors Inc. increased its position in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 34.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 120,649 shares of the company's stock after buying an additional 31,243 shares during the period. UiPath comprises about 0.6% of SoundView Advisors Inc.'s portfolio, making the stock its 21st biggest position. SoundView Advisors Inc.'s holdings in UiPath were worth $1,544,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Parcion Private Wealth LLC acquired a new position in UiPath in the second quarter valued at approximately $145,000. DekaBank Deutsche Girozentrale boosted its holdings in UiPath by 23.2% in the second quarter. DekaBank Deutsche Girozentrale now owns 46,226 shares of the company's stock valued at $592,000 after purchasing an additional 8,690 shares in the last quarter. Chicago Partners Investment Group LLC acquired a new position in UiPath in the second quarter valued at approximately $217,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in UiPath in the second quarter valued at approximately $1,417,000. Finally, Bayforest Capital Ltd boosted its holdings in shares of UiPath by 852.4% in the second quarter. Bayforest Capital Ltd now owns 4,143 shares of the company's stock valued at $53,000 after acquiring an additional 3,708 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.
Insider Activity at UiPath
In other news, CFO Ashim Gupta sold 240,874 shares of the business's stock in a transaction that occurred on Thursday, October 9th. The stock was sold at an average price of $17.28, for a total value of $4,162,302.72. Following the completion of the sale, the chief financial officer directly owned 696,117 shares in the company, valued at approximately $12,028,901.76. The trade was a 25.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Daniel Dines sold 122,734 shares of the business's stock in a transaction that occurred on Wednesday, October 8th. The shares were sold at an average price of $14.89, for a total value of $1,827,509.26. Following the completion of the sale, the chief executive officer owned 613,670 shares of the company's stock, valued at $9,137,546.30. This trade represents a 16.67% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,193,990 shares of company stock worth $31,558,381 over the last three months. 23.19% of the stock is currently owned by corporate insiders.
UiPath Trading Up 2.7%
Shares of NYSE:PATH traded up $0.41 during midday trading on Thursday, hitting $15.44. 1,943,952 shares of the stock were exchanged, compared to its average volume of 14,300,543. The stock has a market cap of $8.20 billion, a P/E ratio of 516.70, a PEG ratio of 6.02 and a beta of 1.07. The company has a 50 day moving average price of $12.83 and a 200-day moving average price of $12.33. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $18.74.
UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The company had revenue of $361.73 million during the quarter, compared to analysts' expectations of $347.36 million. During the same quarter in the previous year, the business earned $0.04 EPS. The firm's revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, equities research analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current year.
Analysts Set New Price Targets
PATH has been the subject of several research analyst reports. DA Davidson initiated coverage on UiPath in a report on Friday, September 5th. They issued a "neutral" rating and a $12.00 price objective for the company. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Friday, September 5th. Truist Financial lowered their price objective on shares of UiPath from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, September 5th. Weiss Ratings reiterated a "sell (d)" rating on shares of UiPath in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded shares of UiPath from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 8th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $13.71.
Get Our Latest Research Report on PATH
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.